Pfizer Inc
NYSE: PFE
$26.17
+$0.52 (+2.0%)
Closing Price on November 25, 2024
PFE Articles
The busiest earnings week of the season has come and gone, but there are still plenty more big names stepping into the spotlight this week.
Published:
24/7 Wall St. has collected a few pharma and biotech catalysts that are coming up on the calendar in November and December.
Published:
The October 13 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.
Published:
Last Updated:
Among the most shorted stocks traded on the New York Stock Exchange, two struggling retailers saw notable growth in their short interest in the latest reporting period.
Published:
Last Updated:
Here are 13 featured spin-offs already underway and potential spin-offs that could be seen in 2017 and into 2018 that could radically change how Wall Street and Main Street evaluate companies ahead.
Published:
Last Updated:
The September 29 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased.
Published:
Last Updated:
The September 15 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.
Published:
Last Updated:
If there is one cure or one treatment that could be the proverbial Holy Grail for a pharmaceutical or biotech company, it would be in a successful treatment of Alzheimer's disease.
Published:
Last Updated:
Apple and 3M weighed on the DJIA Wednesday while McDonald's and Pfizer gave the index a boost.
Published:
Last Updated:
United Technologies, Pfizer, Merck, and Boeing were the stalwarts among the DJIA index stocks on Thursday.
Published:
Last Updated:
Although the markets were mixed on Thursday, major drug manufacturers proved to be one of the more positive segments on the day.
Published:
Last Updated:
The August 31 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.
Published:
Last Updated:
Pfizer, Goldman Sachs, JPMorgan Chase, and Caterpillar helped boost the DJIA to another gain Tuesday.
Published:
Last Updated:
DuPont, General Electric, Pfizer, and UnitedHealth were the leading DJIA gainers Thursday.
Published:
Last Updated:
The August 15 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks dropped.
Published:
Last Updated: